![Novartis Institute for Tropical Diseases, (NITD), NIBR Singapore](https://farm3.staticflickr.com/2856/10876522276_ee765a6440.jpg)
The so called 'living drug' Tisagenlecleucel (aka Kymriah™ by Novartis) is a new CAR-T cell therapy = Docs say pricy gene-altering will violently attack, avert, and might cure harsh B-cell leukaemias
Anagram: Julian Lofts
Image: Novartis AG
Image: Novartis AG